Novartis is eyeing an FDA filing for a second drug in immunoglobulin A nephropathy (IgAN), as the Swiss pharma goes all-in on the rare autoimmune kidney disease from three different angles.
Long Time Gone and the Hardware Store on Maine Street kiowacountyindependent.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kiowacountyindependent.com Daily Mail and Mail on Sunday newspapers.
FDA probes CAR-T therapies' 'serious risk' of secondary cancer fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.